CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Clinical trial NCT04318678 · RECRUITING
Trial details
- NCT number
- NCT04318678
- Sponsor
- St. Jude Children's Research Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2029-07-29
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.